Affiliation:
1. Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
Abstract
The COVID-19 pandemic generated interest in the medicinal applications of messenger RNA (mRNA). It is expected that mRNA will be applied, not only to vaccines, but also to regenerative medicine. The purity of mRNA is important for its medicinal applications. However, the current mRNA synthesis techniques exhibit problems, including the contamination of undesired 5′-uncapped mRNA and double-stranded RNA. Recently, our group developed a completely capped mRNA synthesis technology that contributes to the progress of mRNA research. The introduction of chemically modified nucleosides, such as N1-methylpseudouridine and 5-methylcytidine, has been reported by Karikó and Weissman, opening a path for the practical application of mRNA for vaccines and regenerative medicine. Yamanaka reported the production of induced pluripotent stem cells (iPSCs) by introducing four types of genes using a retrovirus vector. iPSCs are widely used for research on regenerative medicine and the preparation of disease models to screen new drug candidates. Among the Yamanaka factors, Klf4 and c-Myc are oncogenes, and there is a risk of tumor development if these are integrated into genomic DNA. Therefore, regenerative medicine using mRNA, which poses no risk of genome insertion, has attracted attention. In this review, the author summarizes techniques for synthesizing mRNA and its application in regenerative medicine.
Subject
Cell Biology,Developmental Biology,Molecular Biology
Reference153 articles.
1. Rational development of a combined mRNA vaccine against COVID-19 and influenza;Ye;NPJ Vaccines,2022
2. The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review;Ladak;Front. Immunol.,2022
3. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases;Sahu;Mol. Ther.,2019
4. mRNA-based therapeutics: Powerful and versatile tools to combat diseases;Qin;Signal Transduct. Target. Ther.,2022
5. Weng, Y., Li, C., Yang, T., Hu, B., Zhang, M., Guo, S., Xiao, H., Liang, X.J., and Huang, Y. (2020). The challenge and prospect of mRNA therapeutics landscape. Biotechnol. Adv., 40.